Titration: After 30 days, the dose is increased to 7 mg once daily, and can then be escalated to 14 mg once daily, based on tolerance and therapeutic need
If you have obtained your desired weight goal, you can quit using Semaglutide or Tirzepatide
Genitourinary syndrome of menopause (GSM) is driven by low or fluctuating oestrogen and is characterised by vulvovaginal dryness, irritation, dyspareunia, recurrent infections/urinary symptoms, and tissue fragility
A compounded GLP-1 is medicine prepared by a compounding pharmacy based on a prescription
Retrieved from Chen, W., Cai, P., Zou, W., et al
Therefore, whether and how the gut microbiota impacts host locomotion is still unclear